Edgewise Therapeutics, Inc.

EWTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$38.12-2.01%

2026-11-02

Financials

Valuation Metrics

Edgewise Therapeutics, Inc.'s Market Cap is $4.10B. At end of 2025 it was $2.55B. Ranked #1446 of 3,116 in US market (top 46%), #505 of 1,470 on NASDAQ (top 34%), #83 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 31%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$4.10B	US#1,446/3,116 Sec#83/265
Revenue	$0.00	US#2,862/3,116 Sec#194/265
Net Income	$-197M	US—/3,116 Sec—/265
Total Assets	$480M	US#2,774/3,116 Sec#168/265
Net Assets	$448M	US#2,293/3,116 Sec#120/265
Value
P/B	9.15x	US#2,602/3,116 Sec#193/265
FCF Yield	-3.89%	US—/3,116 Sec—/265
Profitability
ROE	-44.02%	US#2,651/3,116 Sec#147/265
ROA	-41.11%	US#2,949/3,116 Sec#193/265
Financial Health
Debt Ratio	7.05%	US#63/3,116 Sec#31/265
Total Debt	$4M	US#2,929/3,116 Sec#224/265
FCF	$-160M	US#2,740/3,116 Sec#189/265
Cash	$72M	US#2,407/3,116 Sec#201/265
Current Ratio	16.24x	US#150/3,116 Sec#42/265
Performance
1Y Return	108.53%	US#58/3,116 Sec#17/265
1M Return	-7.92%	US#2,579/3,116 Sec#181/265
From 52W High	-21.42%	US#1,304/3,116 Sec#68/265
1Y MDD	-24.96%	US#962/3,116 Sec#39/265
Trading
Volume	711,718 shares	US#1,071/3,116 Sec#119/265
Trading Value	$27M	US#1,145/3,116 Sec#79/265
Per Share
EPS	$-1.83	US—/3,116 Sec—/265
BPS	$4.16	US#2,334/3,116 Sec#136/265